Does VEDOLIZUMAB Cause Condition aggravated? 1,373 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,373 reports of Condition aggravated have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 1.9% of all adverse event reports for VEDOLIZUMAB.
1,373
Reports of Condition aggravated with VEDOLIZUMAB
1.9%
of all VEDOLIZUMAB reports
373
Deaths
638
Hospitalizations
How Dangerous Is Condition aggravated From VEDOLIZUMAB?
Of the 1,373 reports, 373 (27.2%) resulted in death, 638 (46.5%) required hospitalization, and 294 (21.4%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 1,373 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which VEDOLIZUMAB Alternatives Have Lower Condition aggravated Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB